From January 19, 2024 to March 31, 2024, the company has repurchased 1,496,000 shares, representing 0.32% for CNY 84.75 million. With this, the company has completed the repurchase of 1,496,000 shares, representing 0.32% for CNY 84.75 million under the buyback announced on January 20, 2024.
Guangzhou Kingmed Diagnostics Group Co., Ltd.
Equities
603882
CNE100002VW1
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
29 CNY | +1.97% |
|
+11.45% | -53.65% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.65% | 1.82B | |
-18.02% | 8.4B | |
+76.76% | 4.42B | |
+14.48% | 2.94B | |
-2.45% | 2.65B | |
-10.44% | 1.83B | |
-13.86% | 1.57B | |
+22.65% | 1.26B | |
-46.45% | 1.09B | |
+16.04% | 977M |
- Stock Market
- Equities
- 603882 Stock
- News Guangzhou Kingmed Diagnostics Group Co., Ltd.
- Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on January 20, 2024.